2Stevens D A,Kan V L,Judson M A,et al.Practice guidelines for diseases caused by Aspergillus.Infectious Diseases Society of America[J].Clin Infect Dis,2000,30(4):696.
3Herbrecht R,Denning D W,Patterson T F,et al.Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis[J].N Engl J Med,2002,347(6):408.
4Walsh T,Patterson T,Langston A,et al.Posaconazole for treatment of invasive aspergillosis in patients who are refractory to or intolerant of conventional therapy:an externally controlled blinded trial[J].Blood,2003,102(11):195a.
5Herbrecht R.Posaconazole:a potent,extended-spectrum triazole anti-fungal for the treatment of serious fungal infections[J].Int J Clin Pract,2004,58(6):612.
6Maertens J,Raad I,Petrikkos G.et al.Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy[J].Clin Infect Dis,2004,39(11):1563.
7Kohno S,Masaoka T,Yamaguchi H,et al.A multicenter,open-label clinical study of micafungin (FK463) in the treatment of deep-seated mycosis in Japan[J].Scand J Infect Dis,2004,36(5):372.
8Sugar A M.Use of amphotericin B with azole antifungal drugs:what are we doing?[J].Antimicrob Agents Chemother,1995,39(9):1907.
9Perea S,Gonzalez G,Fothergill A W,et al.In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp[J].Antimicrob Agents Chemother,2002,46(9):3039.
10Kirkpatrick W R,Perea S,Coco B J,et al.Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis[J].Antimicrob Agents Chemother,2002,46(8):2564.
